Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 15Neoplasms 8cyclopia sequence 7Prostatic Neoplasms 7Polycystic Ovary Syndrome 5Fatigue 5Lung Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pain 3Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Leiomyoma 3Vomiting 2Urinary Bladder Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Nausea 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Insulin Resistance 2Infertility 2Hyperandrogenism 2Hematologic Diseases 2Depression 2Burkitt Lymphoma 2Weight Loss 1

Interventions

Metformin 3fluorodopa F 18 2Clomiphene 2pasireotide 1dapagliflozin 1amino-acid, glucose, and electrolyte solution 1Surveys and Questionnaires 1Sugars 1Solutions 1Saline Solution 1Pioglitazone 1Insulin 1Injections 1Diazoxide 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperinsulinism × Sugars × Clear all
NCT01697566 2025-06-11

An Endometrial Cancer Chemoprevention Study of Metformin

M.D. Anderson Cancer Center

Phase 3 Completed
29 enrolled 12 charts
Other

Hyperinsulinism, Motor Activity, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡